Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could deep breaths before surgery ward off Post-Op confusion?

NCT ID NCT07766603

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This study tests whether practicing deep breathing exercises before surgery can lower the chance of postoperative delirium—a state of confusion and disorientation—in men undergoing robot-assisted prostate removal for prostate cancer. Half of the 50 participants will be taught a simple breathing routine to do daily for about a week before their operation, while the other half receives standard care. Researchers will then monitor all patients for signs of delirium during the first 48 hours after surgery, along with other recovery measures like oxygen levels and hospital stay length.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Preoperative deep breathing exercise training (behavioral intervention)
What this could lead to
If effective, this simple, drug-free approach could offer a low-cost way to reduce postoperative delirium in older surgical patients.
What could go wrong
This is a small pilot study, so results may not be definitive. The intervention's benefit is uncertain, and it may not significantly lower delirium risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged 40 years or older. * Scheduled to undergo elective robot-assisted radical prostatectomy (RARP) at -Akdeniz University Hospital. * Able to communicate and suitable for preoperative and postoperative -cognitive/delirium assessment using the 4AT and Nu-DESC. * Able and willing to provide written informed consent. * Availability of clinical follow-up data during the first 48 postoperative hours. Exclusion Criteria: * Refusal to participate or withdrawal of informed consent. * History of delirium, severe dementia, severe cognitive impairment, or an active neurological disorder that would interfere with delirium assessment. * Active psychosis, severe psychiatric disease, or use of psychoactive medication that could substantially affect cognitive assessment. * Level of consciousness not allowing assessment, or severe hearing or speech impairment preventing adequate communication. * Emergency surgery or failure to complete the planned procedure as robot-assisted radical prostatectomy. * Inability to complete the postoperative 4AT and/or Nu-DESC assessments or substantial missing data affecting the primary analysis. * Inability to tolerate the breathing exercises or insufficient home exercise adherence/follow-up data for the planned analysis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative delirium (POD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergence Delirium Pneumoperitoneum prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Akdeniz University Hospital

    Antalya, Antalya, (532) 256-8442, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.